Royalty Pharma plc
RPRX
Classement en actions
#892
Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a... Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovation in the biopharmaceutical industry in the United States. Its portfolio consists of royalties on approximately 35 marketed therapies and 20 development-stage product candidates that address various therapeutic areas, such as rare disease, oncology, neuroscience, infectious disease, hematology, and diabetes. The company was founded in 1996 and is based in New York, New York.
Prix de l'action
$61.67
Capitalisation boursière
$27.46B
Changement (1 jour)
2.32%
Changement (1 an)
68.35%
Pays
US
Échange Royalty Pharma plc (RPRX)
Catégorie
Healthcare
Historique du rendement du dividende pour Royalty Pharma plc (RPRX)
Le rendement du dividende (TTM) de Royalty Pharma plc (symbole boursier : RPRX) au 2023-12-31 est : 2.85%
Rendement moyen du dividende sur les 5 dernières années : 2.37%
Rendement moyen du dividende sur les 5 dernières années : 2.37%
Historique du rendement du dividende de Royalty Pharma plc (RPRX) de 2015 à 2026
Rendement du dividende à la fin de chaque année (TTM)
| Année | Rendement du dividende | Changez |
|---|---|---|
| 2026 (TTM) | 1.57% | -52.57% |
| 2024 | 3.31% | 16.14% |
| 2023 | 2.85% | 47.67% |
| 2022 | 1.93% | 11.56% |
| 2021 | 1.73% | -15.61% |
| 2020 | 2.05% | -56.29% |
| 2019 | 4.69% | -9.28% |
| 2018 | 5.17% | 10.94% |
| 2017 | 4.66% | 0.00% |
| 2016 | 0.00% | 0.00% |
| 2015 | 0.00% | 0.00% |
Rendements du dividende (TTM) pour des entreprises similaires ou concurrentes
| Entreprise | Rendement du dividende | Pays |
|---|---|---|
| 0.00% |
SE
|
|
| 0.00% |
FR
|
|
| 0.00% |
IT
|
|
| 2.29% |
HK
|
|
| 0.00% |
US
|
